Livforsakringsbolaget Skandia, Omsesidigt United Therapeutics Corp Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in United Therapeutics Corp stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 400 shares of UTHR stock, worth $144,348. This represents 0.01% of its overall portfolio holdings.

Number of Shares

400

Previous 20,850 98.08%

Holding current value

$144,348

Previous $6.64 Million 97.85%

% of portfolio

0.01%

Previous 0.54%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$311.04 - $363.55 $6.36 Million - $7.43 Million	-20,450 Reduced 98.08%	400 $143,000
Q2 2024 Jul 15, 2024	BUY	$228.26 - $319.04 $1.05 Million - $1.47 Million	4,600 Added 28.31%	20,850 $6.64 Million
Q3 2023 Oct 20, 2023	BUY	$211.82 - $248.24 $296,548 - $347,536	1,400 Added 9.43%	16,250 $3.67 Million
Q2 2023 Jul 06, 2023	BUY	$205.19 - $232.99 $61,557 - $69,897	300 Added 2.06%	14,850 $3.28 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $2.31 Million - $3 Million	10,850 Added 293.24%	14,550 $3.26 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $129,024 - $151,256	700 Added 23.33%	3,700 $798,000
Q1 2020 Apr 22, 2020	SELL	$79.39 - $115.35 $98,364 - $142,918	-1,239 Reduced 29.23%	3,000 $284,000
Q2 2019 Jul 19, 2019	SELL	$76.06 - $120.81 $30,424 - $48,324	-400 Reduced 8.62%	4,239 $331,000
Q3 2018 Oct 26, 2018	SELL	$113.81 - $129.46 $113,810 - $129,460	-1,000 Reduced 17.73%	4,639 $593,000
Q4 2017 Jan 18, 2018	SELL	$118.58 - $151.28 $23,716 - $30,256	-200 Reduced 3.43%	5,639 $834,000
Q3 2017 Oct 12, 2017	BUY	$114.6 - $136.81 $669,149 - $798,833	5,839	5,839 $685,000

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt United Therapeutics Corp Transaction History